Uncategorized
Juvenile Macular Degeneration (Stargardt Disease) Pipeline Review, H1 2020 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Juvenile Macular Degeneration (Stargardt Disease) Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This pipeline guide Juvenile Macular Degeneration (Stargardt Disease) Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA